Propylene glycol
These manufacturers do not place this the same way.
scroll for all 13 products →
| Section | Zydus Pharmaceuticals UK Ltd1mg Oral Solution | Viatris (formerly Mylan or Upjohn)10mg Tablets | Ipca Laboratories UK Ltd10mg Tablets | Dr. Reddy's Laboratories (UK) Ltd10mg Tablets | Flamingo Pharma (UK) Ltd10mg Tablets | Sandoz Limited10mg Tablets | Amarox Limited10mg Tablet | Aurobindo Pharma - Milpharm Ltd.10mg Tablets | Rosemont Pharmaceuticals Limited1mg Oral Solution | Amarox Limited5mg Tablets | Sandoz Limited5mg Tablets | Zentiva2.5mg Tablets | Viatris (formerly Mylan or Upjohn)10mg Tablets |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ContraindicatedThe label says it must not be used. | |||||||||||||
| WarningThe label says it can be used, with care. | |||||||||||||
| InteractionThe label says another medicine affects it. | Interaction | ||||||||||||
| PregnancyThe label gives advice for pregnancy or breastfeeding. | |||||||||||||
| ExcipientThe label lists it as an ingredient, not a restriction. |
- Interaction
Source SmPC ↗3811–4024 of 4024 characters
n adult weighing 70 kg) or .009 mg/100 ml (a child 7 years of age and weighing). For comparison, for an adult drinking a glass of wine or 500 ml of beer, the BAC is likely to be about 50 mg/100 ml. Co-administration with medicines containing e.g. propylene glycol or ethanol may lead to accumulation of ethanol and induce adverse effects, in particular in young children with low or immature metabolic capacity.
- Not in scanned sections
Viatris (formerly Mylan or Upjohn)
Source SmPC ↗- Source SmPC ↗
Dr. Reddy's Laboratories (UK) Ltd
Source SmPC ↗- Source SmPC ↗
- Source SmPC ↗
- Source SmPC ↗
Aurobindo Pharma - Milpharm Ltd.
Source SmPC ↗Rosemont Pharmaceuticals Limited
Source SmPC ↗- Source SmPC ↗
- Source SmPC ↗
- Source SmPC ↗
Viatris (formerly Mylan or Upjohn)
Source SmPC ↗
No match in sections 4.3, 4.4, 4.5, 4.6, 6.1 as read for this label. Not the same as the label being silent.
- §4.3 read
- §4.4 read
- §4.5 read
- §4.6 read
- §6.1 read